Regulatory Perspectives on Data Safety Monitoring Boards: Protecting the Integrity of Data

ISSN： 0114-5916

Source： Drug Safety, Vol.27, Iss.1, 2004-01, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhancing Trial Integrity by Protecting the Independence of Data Monitoring Committees in Clinical Trials

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 5, 2014-09 ,pp. : 968-975

Taylor & Francis Ltd

Access to resources Recommend Favorite

Operational Guidelines for the Establishment and Functioning of Data and Safety Monitoring Boards

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 1, 2006-01 ,pp. : 25-36

Adis International

Access to resources Recommend Favorite

Data Safety Monitoring Boards: Their Role in Drug Development and Pharmaceutical Trials

By Boardman H.

International Journal of Pharmaceutical Medicine, Vol. 17, Iss. 1, 2003-01 ,pp. : 39-46

Adis International

Access to resources Recommend Favorite

A Review of: “Data and Safety Monitoring Committees in Clinical Trials, by J. Herson”

By Gallo Paul

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 1168-1171

Taylor & Francis Ltd

Access to resources Recommend Favorite

Truncated Robust Distance for Clinical Laboratory Safety Data Monitoring and Assessment

By Lin Xiwu

Journal of Biopharmaceutical Statistics, Vol. 22, Iss. 6, 2012-11 ,pp. : 1174-1192

Taylor & Francis Ltd

Access to resources Recommend Favorite